I

InterMune

86 employees

InterMune is focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Developer Platform
Therapeutics
Pharmaceuticals and Treatment Therapies

Date founded

1998

Funding rounds raised

I

InterMune raised undisclosed on January 1, 1999

Investors: Sofinnova Ventures, Russia technology fund

FAQ